Haoxi Health Technology Limited Class A Ord Shar (HAO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 12-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,877 | 1,292 | 970 | N/A | 245 |
| Depreciation Amortization | 372 | 11 | 8 | N/A | 2 |
| Accounts receivable | -254 | -218 | -4 | N/A | 666 |
| Accounts payable and accrued liabilities | -497 | 623 | -1,201 | N/A | -1,604 |
| Other Working Capital | -1,842 | -2,050 | -1,850 | N/A | -763 |
| Other Operating Activity | -5,014 | -405 | 1,205 | 0 | 780 |
| Operating Cash Flow | $-3,358 | $-748 | $-872 | $N/A | $-675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -55 | -46 | N/A | -9 |
| Purchase Sale Intangibles | -2,080 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -3,580 | -3,074 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,580 | $-3,129 | $-46 | $N/A | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,034 | 478 | 453 | N/A | 330 |
| Debt Issued | N/A | N/A | 259 | N/A | N/A |
| Common Stock Issued | 10,956 | 8,975 | 1,994 | N/A | 164 |
| Other Financing Activity | -4,087 | -130 | -904 | 0 | 439 |
| Financing Cash Flow | $8,903 | $9,324 | $1,803 | $N/A | $933 |
| Exchange Rate Effect | -2 | 6 | 25 | N/A | -16 |
| Beginning Cash Position | 6,656 | 1,203 | 294 | N/A | 56 |
| End Cash Position | 8,619 | 6,656 | 1,203 | N/A | 294 |
| Net Cash Flow | $1,963 | $5,453 | $910 | $N/A | $238 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,358 | -748 | -872 | N/A | -675 |
| Capital Expenditure | N/A | -55 | -46 | N/A | -9 |
| Free Cash Flow | -3,358 | -803 | -918 | 0 | -684 |